FISPB
VKTX icon

Fideuram - Intesa Sanpaolo Private Banking’s Viking Therapeutics VKTX Stock Holding History

Fideuram - Intesa Sanpaolo Private Banking’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.72M Buy
44,066
+82
+0.2% +$2.65K 0.05% 243
2026
Q1 		$1.43M Sell
43,984
-100,573
-70% -$3.23M 0.05% 255
2025
Q4 		$5.09M Buy
+144,557
New +$5.12M 0.18% 125

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Fideuram - Intesa Sanpaolo Private Banking's VKTX Position: Q2 2026 in Review

Fideuram - Intesa Sanpaolo Private Banking increased its Viking Therapeutics (VKTX) stake by 0.19% in Q2 2026, buying an estimated $2.65K and bringing the position to 44,066 shares worth $1.72M. The position accounts for 0.05% of the portfolio, ranked #243.

Fideuram - Intesa Sanpaolo Private Banking first reported a position in VKTX in Q4 2025 and has held it in 3 quarters since. The position peaked at $5.09M in Q4 2025. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Fideuram - Intesa Sanpaolo Private Banking held 44,066 shares of Viking Therapeutics worth $1.72M as of Q2 2026.
  • Fideuram - Intesa Sanpaolo Private Banking bought 82 Viking Therapeutics shares in Q2 2026, an estimated $2.65K.
  • Viking Therapeutics made up 0.05% of Fideuram - Intesa Sanpaolo Private Banking's portfolio in Q2 2026, its #243 holding.
  • Fideuram - Intesa Sanpaolo Private Banking first reported a position in Viking Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Fideuram - Intesa Sanpaolo Private Banking's Viking Therapeutics position peaked at $5.09M in Q4 2025.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Fideuram - Intesa Sanpaolo Private Banking's 13F filing for Q2 2026, filed 23 Jul 2026.